Veklich T O, Shkrabak O A, Rodik R V, Boĭko V I, Kal'chenko V I, Kosterin S O
Ukr Biokhim Zh (1999). 2010 Jan-Feb;82(1):21-33.
It was found that calixarene C-107 (5,17-diamino(2-pyridyl)methylphosphono-11,23-di-tret-butyl-26,28-dihydroxy-25,27-dipropoxycalix[4]arene) could effectively reduce Na+,K(+)-ATPase activity of the myometrium cell plasmatic membranes (the value of the apparent constant of inhibition I0.5 was 33 +/- 4 nM) while it practically did not influence the "basal" Mg2(+)-ATPase activity of the same membrane. In comparative experiments, we have shown that the model calixarene C-150--the calixarene "scaffold" (26,28-dihydroxy-25,27-dipropoxycalix[4]arene), and the model compound M-3 (4-hydroxyaniline(2-pyridine)methylphosphonic acid)--a fragment of the calixarene C-107, had practically no influence on the enzymatic activities of Na+,K(+)-ATPase and Mg(2+)-ATPase over a wide range of concentrations. Hence, the influence of calixarene C-107 on Na+,K(+)-ATPase activity was caused by the joint action of two aminophosphonic substituents on the upper rim of the calixarene bowl. The isomer of calixarene C-107--calixarene C-160 (5,11-diamino(2-pyridyl)methylphosphono-17,23-di-tret-butyl-26,28-dihydroxy-25,27-dipropoxycalix[4]arene) also did not influence the Na+,K(+)-ATPase and Mg(2+)-ATPase activities of plasmatic membrane of myometrium cells. We carried out molecular modeling of calixarenes C-107 and C-160 and showed differences in interatomic distance between aminophosphonic substituents of mentioned calixarenes. We came to the conclusion that spatial structure of calixarene C-107, namely localization of two aminophosphonic substituents in 5,17 position of the upper rim of this calixarene, is crucial for inhibition of Na+,K(+)-ATPase activity. Using laser correlation spectroscopy it was found that the 100 microM solution of calixarene C-107 and 2.5% DMSO had microparticles with size range from 100 nm to 10 microm. Plasma membrane vesicles had average hydrodynamic diameter 401 +/- 17 nm, but after interaction of these vesicles with calixarene C-107 we have registered the creation of some particles with sizes greater than 10 microm. Therefore membrane vesicles agglutinated to each other and/ or to calixarene microparticles.
研究发现,杯芳烃C - 107(5,17 - 二氨基(2 - 吡啶基)甲基膦酰基 - 11,23 - 二叔丁基 - 26,28 - 二羟基 - 25,27 - 二丙氧基杯[4]芳烃)能有效降低子宫肌层细胞质膜的Na⁺,K⁺ - ATP酶活性(表观抑制常数I0.5的值为33±4 nM),而实际上对同一膜的“基础”Mg²⁺ - ATP酶活性没有影响。在对比实验中,我们表明模型杯芳烃C - 150——杯芳烃“骨架”(26,28 - 二羟基 - 25,27 - 二丙氧基杯[4]芳烃)以及模型化合物M - 3(4 - 羟基苯胺(2 - 吡啶)甲基膦酸)——杯芳烃C - 107的一个片段,在很宽的浓度范围内对Na⁺,K⁺ - ATP酶和Mg²⁺ - ATP酶的酶活性实际上没有影响。因此,杯芳烃C - 107对Na⁺,K⁺ - ATP酶活性的影响是由杯芳烃碗状结构上缘的两个氨基膦酸取代基的共同作用引起的。杯芳烃C - 107的异构体——杯芳烃C - 160(5,11 - 二氨基(2 - 吡啶基)甲基膦酰基 - 17,23 - 二叔丁基 - 26,28 - 二羟基 - 25,27 - 二丙氧基杯[4]芳烃)也不影响子宫肌层细胞质膜的Na⁺,K⁺ - ATP酶和Mg²⁺ - ATP酶活性。我们对杯芳烃C - 107和C - 160进行了分子建模,并展示了上述杯芳烃的氨基膦酸取代基之间原子间距离的差异。我们得出结论,杯芳烃C - 107的空间结构,即该杯芳烃上缘5,17位两个氨基膦酸取代基的定位,对于抑制Na⁺,K⁺ - ATP酶活性至关重要。使用激光相关光谱法发现,100 microM的杯芳烃C - 107溶液和2.5%的二甲基亚砜含有尺寸范围从100 nm到10微米的微粒。质膜囊泡的平均流体动力学直径为401±17 nm,但在这些囊泡与杯芳烃C - 107相互作用后,我们记录到形成了一些尺寸大于10微米的颗粒。因此,膜囊泡相互聚集和/或与杯芳烃微粒聚集。